PipelineReview.com La Merie, S.L.
Categories
Biotech & generics
Business & market
Cardiovascular & blood
Company Profiles
Dermatology
Diagnostics & biomarkers
Gastrointestinal
Genitourinary & gynecology
Healthcare
Infectious & toxicology
Medical devices
Medical Equipment
Metabolism & endocrine
Metabolism& endocrine
Neurology & psychiatry
Oncology
Ophthalmology & otorhino
Orthopedics & anesthesia
Pulmonary & respiratory
Research & Development
Rheumatoid & autoimmune
Target pipeline
Technologies
Periodicals
Publishers
BioSeeker Group
Business Insights
Business Monitor International
Datamonitor
Espicom
GBI Research
GlobalData
Insight Pharma Reports
Jain PharmaBiotech
Kalorama Information
La Merie Publishing
Life Science Analytics
MarketsandMarkets
Scientia Veritas
Visiongain
Product Lines
Analytical Tool
Brief Report
Commercial & Pipeline Insight
Commercial & Pipeline Perspective
Commercial Insight
Competitor Analysis
Database
Drug Pipeline Report
Drug Pipeline Update
Drug Profile
Emerging Company Profile
Financial Deals Industry Tracker
Full Report
Insight Pharma
PharmaVitae Profile
Pipeline Insight
Pipeline/Commercial Insight
Premium Company Profile
Self-Service Products
Stakeholder Insight
Stakeholder Opinions
Triple Analysis
Pipeline Review Online Store - Biotech Reports by La Merie, Datamomitor, Business Insight, Kalorama, Life Science Analytics, Visiongain and Sciencia Veritas.
Reports on biopharmaceutical R&D provide competitive information and in-depth analysis from publishers La Merie, Datamomitor, Business Insight, Kalorama, Life Science Analytics, Visiongain, andSciencia Veritas. Secure Online payment with credit card and download or mail delivery of the report in PDF format.
Featured Products
Pipeline Insight: Biologic Targeted Cancer Therapies - Next generation jostles for market position8,672  EUR
[$11,400.00 USD]
Pharmaceutical Company Outlook to 20145,782  EUR
[$7,600.00 USD]
Benchmarking the Pharmaceutical Market by Drug Delivery to 20145,782  EUR
[$7,600.00 USD]
New Products For January
Men's Health Therapeutics Market to 2017 - Availability of Generic Sildenafil from 2012 to Restrain Market Growth2,663  EUR
[$3,500.00 USD]
Veterinary Vaccines Market to 2017 - Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms2,663  EUR
[$3,500.00 USD]
Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods2,663  EUR
[$3,500.00 USD]
Antipsychotics Market to 2017 - Patent Expiries for Zyprexa, Abilify, Seroquel and Geodon and the Launch of Generic Versions Will Limit Commercial Opportunities for Pipeline Molecules2,663  EUR
[$3,500.00 USD]
Endpoints - Clinical Trials in Cardiovascular Disorders - Optimal Use of Surrogate Endpoints and Clinical Biomarkers are Key Determinants of Success2,663  EUR
[$3,500.00 USD]
Antifungals Market to 2017 - Generic Erosion of Major Polyenes, Azoles, Allylamines and Echinocandins to Slow Value Growth2,663  EUR
[$3,500.00 USD]
Musculoskeletal Disorders Therapeutics Market to 2017 - Osteoarthritis Market to Decline with Patent Expiry of Celebrex in 20142,663  EUR
[$3,500.00 USD]
Dermatology Therapeutics Market to 2017 - Alopecia Market is Forecast to Decline Due to Patent Expiry of Finasteride in 2013 and Weak Pipeline2,663  EUR
[$3,500.00 USD]
High-Content Analysis: Technologies, Applications, and Market Dynamics1,898  EUR
[$2,495.00 USD]
Currencies
Shopping Cart more
0 items
Quick Find
Any wordAll words
Exact Phrase
Use keywords to find the product you are looking for.
Advanced Search
Bestsellers
01.Competitor Analysis: Erythropoietin (EPO)
02.Competitor Analysis: Anti-Obesity Biologics
03.Competitor Analysis: IGF-1R Antagonists
04.Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors
05.Competitor Analysis: Coagulation Factors
Specials more

Biosimilars Approval Pathways in the US and Europe - Development and Approval of Biosimilar mABs May Face Tough Regulatory Environment
2,663  EUR
[$3,500.00 USD]

2,263  EUR
[$2,975.00 USD]
Newest Product more
Solid Organ Transplant Immunosuppressant Market to 2018 - Limited Availability of Donors Drives Improvements in Organ Procurement and Preservation Methods
2,663  EUR
[$3,500.00 USD]
La Merie Business Intelligence

For immediate assistance, please call us during business hours: Mon-Fri 09:00am - 18:30pm; GMT+01

La Merie S.L | Travesía Balmins, 7, Bajos, 2ª | E-08870 Sitges | Spain | T +34 93 342 91 97 | F +34 93 342 91 98 | Email info@lamerie.com | Internet www.lamerie.com
All contents © by La Merie S. L


Secure Websites